A competitive enzyme-linked immunosorbent assay has been standardised for the detection of antibodies to rinderpest virus in sera from cattle, sheep and goats. The test uses a neutralising monoclonal antibody (MAb) directed against the haemagglutinin protein of rinderpest virus. The test is specific for rinderpest, as it failed to detect antibodies to peste des petits ruminants virus in convalescent goat sera. A 45% inhibition of the binding of the MAb to the antigen was used as the cut-off point for deciding the rinderpest status of the test samples. The specificity and sensitivity of the test and the stability of the test reagents were determined and compared to the results obtained using a commercial kit with approximately 1,200 serum samples from cattle, sheep and goats in India. The current test compared very well with the commercial kit. The test is expected to be extremely useful for sero-monitoring and sero-surveillance of rinderpest in countries which are actively pursuing a rinderpest eradication programme.
Introduction
Rinderpest is a highly contagious and acute febrile disease of cattle, buffalo and yaks, characterised by ulcers in the buccal cavity, necrosis of the gastro-intestinal tract, diarrhoea, dehydration and death (18) . The presence of rinderpest imposes a considerable economic burden on a country through restricted export opportunities for livestock and livestock products. Mass vaccination campaigns can help reduce the incidence and contribute to the eventual eradication of the disease. To monitor this process, a rinderpest-specific serological test is required, both to estimate the prevalence of immunity in vaccinated animals (seromonitoring) and to verify the absence of circulating virus when vaccination campaigns are replaced by surveillance techniques (serosurveillance and clinical surveillance). The situation becomes more complicated when both rinderpest and the closely-related virus of peste des petits ruminants (PPR) are simultaneously present. Although PPR is predominantly an infection of small ruminants, asymptomatic PPR infection of in-contact cattle may occur (8) . Where such a scenario exists, the ability to make accurate serological determinations of substantial numbers of samples collected within well designed sampling frames is vital. Under these circumstances, a test is required that is simple and rapid to perform, while being sensitive, accurate and cost-effective. The enzyme-linked immunosorbent assay (ELISA) technique fulfils all of these requirements. Detection of antibodies to rinderpest or PPR viruses by competitive (c)-ELISA has been reported previously (1, 16, 20) . efficacy of this test with the only available commercial kit. If found suitable, this test will be used in serosurveillance in India, where a programme for verifying the total eradication of rinderpest infection is being actively pursued.
Materials and methods

Virus/antigen
Tissue culture rinderpest vaccine (TCRPV) of the RBOK strain (19) was used, after 101 passages in primary calf kidney culture. The virus was passaged a further three to six times in Vero cells for antigen production. The antigen grown on Vero cells was used for both the production of MAbs and the standardisation of the c-ELISA.
Production of monoclonal antibodies
Monoclonal antibodies were produced using a standard protocol (12) . BALB/c mice were immunised using discontinuous sucrose-gradient purified TCRPV (6) . Fusion was performed using polyethylene glycol (PEG, molecular weight: 1,300-1,600), and 96-well plates were used for sub-cloning by the limiting dilution' method. Clones were screened for selection by an indirect ELISA, using the same antigen that was used to immunise the mice.
Preparation of the antigen for competitive enzyme-linked immunosorbent assay
For bulk production of the antigen, Vero cells were grown in roller bottles, and were infected with TCRPV at a multiplicity of infection of 0.01 cell culture infective dose 50 (CCID 50 )/cell. The infected cells were harvested when 70%-80% of the cells showed a cytopathic effect (CPE), after which the culture was freeze-thawed three times to release the intracellular virus into the culture fluid. -Cell debris was removed after centrifugation at 1,000 g for 30 min. The virus in the supernatant was precipitated overnight at 4°C using PEG-6,000 (8% weight/volume) in the presence of sodium chloride (2.3% final concentration). The precipitate was collected by centrifugation at 8,000 g for 30 min, and was then resuspended in phosphate-buffered saline (PBS) (l/50th of the original volume) with mild homogenisation. The homogenised material was lightly centrifuged at 8,000 g for 30 min, and the supernatant was further centrifuged at 97,000 g for 2 h over a 65% sucrose cushion. The virus band obtained above the 65% sucrose was collected and used as ELISA antigen at an appropriate dilution.
Selection and characterisation of the monoclonal antibody
The panel of MAbs produced against TCRPV was screened for specificity by testing against both rinderpest and PPR virus antigens in an indirect ELISA. The MAbs showing maximum specificity towards rinderpest virus were selected for further evaluation in a c-ELISA using bovine rinderpest immune sera or bovine rinderpest negative sera with the parameters described by Wright (22) .
The virus neutralisation activity of the selected MAb was studied in a 96-well micro-titre plate using approximately 100 CCID 50 /well of TCRPV (4). Two-fold dilutions of the MAb in 50 µl volumes were incubated with the virus for 1 h at 37°C. The mixture containing MAb and virus was then transferred to 24 h-old Vero cell monolayers in a 96-well cell culture plate. The cells were observed daily for CPE and the neutralising titre was determined seven days post infection.
The isotype of the selected MAb was determined using a 'mouse isotyping kit'. A radio-immuno precipitation assay (3) was performed to determine the polypeptide against which the selected MAb was directed.
Enzyme-linked immunosorbent assay procedures
A c-ELISA was standardised following the basic protocols described by other workers (1, 15) , with certain modifications. Briefly, the ELISA plates were coated with 50 µl/well of the optimal concentration of the antigen. The concentration used in the test was determined on the basis of the results obtained in the indirect ELISA, where varying dilutions of antigen were made to react with excess MAb. The plates were incubated at 37°C for 1 h in stationary phase. However, every 15 min, the plates were shaken for 2 min by hand in a rotatory fashion, simulating the motions of an orbital shaker. The plates were then washed three times with 0.01M PBS (diluted 1:4). To each well of the plates, 40 µl of blocking buffer (PBS, 0.2% rinderpest negative bovine serum, 0.2% Tween-20) was added. Next, 10 µL of test serum samples, including strong positive, weak positive and negative control in duplicate sets, were added to designated wells. Immediately after this, 50 µl of MAb (diluted 1:250 in blocking buffer) was added to each well of the plates, except the wells for conjugate controls. The volume in the MAb and conjugate control wells were adjusted with blocking buffer. The plates were tapped gently to mix the contents in the wells and were incubated for 75 min at 37°C, with intermittent shaking as described above. After further washing, 50 µl of anti-mouse conjugate, diluted 1:1,000 in blocking buffer, was added to all the wells of the plate and incubated for 1 h at 37°C with intermittent shaking. The plates were washed and substrate chromophore solution (o-phenylenediamine dihydrochloride containing H 2O2 ), pre-warmed to 37°C, was added. Wells were observed for the development of colour and the reaction was stopped using 1M H 2 SO 4 to obtain an expected optical density (OD 492 ) range of 0.6 ± 0.3 in MAb control wells (normally within 15 min). Percentage inhibition (PI) of all the controls and samples were calculated using the following formula: 
Test samples
Test samples included sera from cattle, buffalo, sheep and goats, either stored in the repository of the Indian Veterinary Research Institute (IVRI), Mukteswar, or collected from different parts of India, during rinderpest sero-monitoring and sero-surveillance. Sera from cattle experimentally infected with virulent rinderpest virus (Hisar and Bangalore isolates -, from India), goats with Edwards' caprinised rinderpest virus (10) and rabbits with Nakamura III strain of lapinised rinderpest virus (17) , were also incorporated in the study. Known PPR convalescent sera from goats were also included for evaluating any cross-reactivity with PPR antibodies.
Determination of cut-off values for relative specificity and sensitivity of the assay
The cut-off value for determining the status of a serum sample was based on the results of the analysis of the mean and standard deviation (SD) of the negative population. The mean of the test values from uninfected animals + 2 SD was used as the cut-off for the c-ELISA (13).
The relative sensitivity and specificity of the test were compared with the results of a commercial kit (used as the 'gold standard'), employing known positive and negative samples. The sensitivity of the assay was calculated by dividing the number of true positive sera detected using these reagents in c-ELISA by the total number of positive samples as detected by the commercial kit. Relative specificity was calculated by dividing the number of negative sera in the new system by the total number of negative samples in the commercial kit.
Repeatability, reproducibility and stability of reagents
The freeze-dried reagents were tested repeatedly at the IVRI, Mukteswar, with different workers employing the same set of reagents and a control set of serum samples comprising, among others, known positive, weak positive and negative sera for rinderpest antibodies. The stability of the reagents with respect to freezing and thawing and the shelf-life of the reagent (up to one year) was assessed. The coefficient of variation between and within runs of the assay was calculated for samples using standard statistical formulae (available in the EDI software used).
Results
Selection and characterisation of the monoclonal antibody
Of the available panel of MAbs against rinderpest, clone D7.26b was found to be the most suitable for standardisation of c-ELISA for the purpose of sero-surveillance. This MAb culture supernatant had a neutralising titre of 3,125 against 100 CCID 50 of TCRPV. This neutralisation was specific to rinderpest and even undiluted culture supernatant did not neutralise PPR infectivity (100 CCID 50 ) in cell culture. The MAb was found to be of immunoglobulin (Ig) G 1 isotype and directed against the haemagglutinin (H) polypeptide of rinderpest virus on the basis of radio-immunoprecipitation assay. In an indirect ELISA, an OD 490 value of 1.0 could be obtained, even when the MAb was diluted up to 1:1,000, in the presence of excess antigen (Fig. 1 ). The binding of the MAb to the antigen was inhibited in the presence of standard rinderpest positive cattle serum, but not in the presence of negative serum. The PI of binding of the MAb in the presence of positive serum was more than 45, even when the MAb was diluted up to 1:10,000 (Fig. 2) . However, the optimum inhibition of > 90% was observed when the MAb was diluted between 100 and 1,000-fold. Hence, a standard 1:250 dilution of the MAb was used for subsequent c-ELISA tests. 
Standardisation of a competitive enzyme-linked immunosorbent assay
The concentration of the antigen used in the test was determined on the basis of the results obtained in the indirect ELISA, where varying dilutions of antigen were made to react with excess MAb (Fig. 3) . The antigen dilution of 1:150 was estimated to result in an OD 490 value of 0.6 ± 0.3. Known rinderpest positive serum, but not control negative serum, inhibited the binding of the MAb to the coated antigen in the plate, when the MAb and serum were added simultaneously. The dilution curve of the positive serum vis-à-vis binding of the MAb to the antigen demonstrates that this competition for the antigen is specific (Fig. 4) . The inhibition of MAb binding was always approximately 90% with anti-rinderpest bovine hyperimmune serum, whereas 45% to 90% inhibition was observed with post-vaccine or post-infection sera. Known negative serum samples (N = 528) from cattle, buffalo, sheep and goats had a population mean of 4.11%, with an SD of 20.29%. A cut-off point was selected equal to the sum of the mean of the negative reference serum and twice the SD (4.11 + 40.58 = 44.69 or 45%). Consequently, 45% was set as the cut-off point (12) for determining the status of a given serum sample (negative or positive) (Fig. 5) . Serial two-fold dilutions of the antigen were coated on ELISA plates and the bound MAb was traced with rabbit anti-mouse horseradish peroxidaseconjugate. The arrow indicates the dilution of the antigen giving an optical density (OD 492 ) of 0.6
Coefficient of variance between the optical densities
Out of approximately 1,000 serum samples tested in duplicate wells, the coefficient of variation between the wells was less than 10% for most of the samples (88.8%). Of the remaining samples, 82.5% demonstrated a variation between 10% and 26% when one well of the duplicate was in the periphery of the plate. Relative sensitivity of the assay in comparison to a commercial kit A total of 945 serum samples from cattle, buffalo, sheep and goats of varying immune status with respect to rinderpest (e.g. negative, vaccinated and convalescent) were tested by the standardised c-ELISA. All the samples were tested simultaneously with a commercially-available c-ELISA kit.
The comparative results are illustrated in Figures 6, 7 and 8 . Sample-to-sample regression analysis of results on 561 samples obtained using both the test systems was found to be significant at a 1% confidence level on the basis of the F test applied to the R 2 (R = 0.62). Furthermore, the t test applied to the estimates of the parameters was statistically significant at the 1% confidence level (Fig. 6b) .
The relative sensitivity and specificity of the system used by the authors, compared to the commercial source, were determined using a two-sided contingency table (11) . The sensitivity of the system described here versus the commercial kit is 136/139 = 0.978 (97.8%). Similarly, the specificity of the system is 770/806 = 0.955 (95.5%), when compared to the kit. In reverse, the relative sensitivity of the commercial kit versus the new system is 136/172 = 0.791 (79.1%) and specificity is 770/773 = 0.996 (99.6%). The data for the above analysis are presented in Figure 9 . A batch of 198 serum samples from PPR-convalescent goats (which had detectable virus neutralising antibodies) were also tested to assess the specificity of the test. The antibodies to PPR virus did not interfere at all with the binding of the MAb to the antigen. The result was similar when the commercial kit was employed for assessment of these sera. However, a higher PI was observed with the commercial kit, even within the negative range (Fig. 10) .
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Stability of the reagents and repeatability of the assay
The reactivity of various reagents after different cycles of freezing and thawing indicated that no significant changes occur in the performance of these reagents. The PI values of different control panels ranged within the limits fixed for the purpose (Fig. 11) . To investigate the inherent variations between runs of the assay, three serum samples with known immune status (strong positive, weak positive and negative) were repeatedly tested in duplicate or quadruplicate, in thirty-three runs. To regulate the specificity and sensitivity of the assay, the upper and lower limits of PI values were fixed as the calculated mean ± 2 SD of each control panel (Table I ).
Discussion
For the success of any disease eradication programme, a rigorous surveillance campaignis extremely important. Quick On the basis of nucleotide sequencing, three different lineages of rinderpest virus have been established, two of which are prevalent in Africa and one in Asia (5). Although the selected MAb was raised against TCRPV (RBOK strain), the MAb failed to bind to the same antigen in the presence of animal serum with antibodies to TCRPV, virulent rinderpest virus (Indian Hisar and Bangalore isolates), lapinised rinderpest virus (17) virulent for rabbits and Edwards' caprinised virus (10) . Since all these viruses originate in different geographical regions, and as rinderpest virus is antigenically stable, the selected MAb is expected to react uniformly and in a stable manner in a c-ELISA. However, failure of antibodies to PPR, in competition with the MAb, to bind to the antigen, prove that this assay can be efficiently used in sero-surveillance for rinderpest in countries where both rinderpest and PPR are present.
The assay has been standardised to provide the most optimal conditions for performance (7) . The assay has also been calibrated following the international norms for standardisation and validation of serological assays for the diagnosis of infectious diseases (13, 22) . The antigen used in the assay is a semi-purified cell-free TCRPV. All the biological reagents (antigens, MAbs and negative, weak positive and strong positive serum controls) were prepared in bulk and lyophilised before assessing the comparative performance. The performance of all the reagents has been tested, including repeated freezing and thawing of the critical standards, e.g. positive and negative control sera, conjugate, MAb and the antigen. The necessity to incorporate three standard sera, i.e. strong positive, weak positive and negative, has been emphasised in order to reduce inter-plate variation and to ensure accuracy (14, 16) . No significant change in performance of the critical reagents occurred under these conditions. When the performances of various serum controls were analysed with the confidence limit set at 2 x SD, some overlapping between the upper limit of the weak positive and lower limit of the strong positive serum controls was detected. This overlapping did not affect the results, but the strength of the weak positive control serum needs to be reduced before the assay is released for field application. The comparative performance of the test was assessed over a period of more than one year and the efficiency of the reagents had not diminished after one year of storage in a refrigerator in lyophilised form. The reagents can therefore be safely transported and used in distant laboratories over a long period of time. This will enhance the capabilities of these reagents to be made available as a diagnostic kit both for sero-surveillance and sero-monitoring against rinderpest.
The c-ELISA developed was found to be a sensitive assay for the detection of specific antibodies to rinderpest virus. The test could detect approximately 97.8% of positive sera from various species of animals, compared to 79.18% with the approved commercial kit. This difference in sensitivity between the two systems could have a number of explanations, including lowered cut-off value (45%), different nature of the antigen (i.e. cell-free semi-purified virus), differences in the affinity or avidity of the MAb employed. A difference in sensitivity was observed mostly in those serum samples which were marginally negative in any one of the two systems. Consequently, some of the samples showing a PI value between forty and fifty in the commercial kit, may have managed to cross the 45% inhibition threshold in the new system, to be identified as positive for rinderpest antibodies. When the specificity of the assay was compared, the new ELISA showed a specificity of 95.5%, compared to 99.6% with the commercial kit. Unfortunately, only a very small percentage (12%) of positive samples, in either test were from convalescent animals. The remaining positive samples were from vaccinated animals. Since India is maintaining a 'provisionally-free' status in respect to rinderpest (21) , the convalescent sera tested were those available in the repository. Attempts are being made to determine the comparative efficacy of the reagents in detecting antibodies to rinderpest virus of different lineages, in collaboration with the designated FAO World Reference Laboratory for Rinderpest.
Overall, the reagents in the system under development always showed lower PI values than the reagents in the commercial kit, when the negative samples were assessed. As a result, many such samples had negative PI values, indicating higher OD values obtained with negative samples than in the MAb control. This could have been due to either inadequate washings or non-specific attachment of the conjugate to some components of bovine serum or the antigen used in the assay. In positive samples, such reactivity of the conjugate was masked, due to higher PI values.
Despite collecting serum samples within three weeks of vaccination, a poor immune response was observed by the assay in a goat farm where rinderpest vaccine had been used (Fig. 7) . The accredited kit also produced the same result. An inquiry revealed that the farm was incurring huge losses due to an outbreak of PPR. To reduce the incidence of PPR, vaccination with TCRPV was undertaken soon after the outbreak. However, the circulating antibodies to PPR may have prevented the TCRPV virus from eliciting an immune response. This corroborates the findings of Anderson and McKay (2) , that antibodies to PPR could prevent the development of an immune response to rinderpest vaccine. In approximately half of the bovine serum samples collected within an area in which the immunisation campaign was withdrawn most recently, antibody to rinderpest virus could be detected by the c-ELISA, even twelve to fourteen months following vaccination (Fig. 8) . The test is therefore competent to detect antibodies to rinderpest virus in susceptible species (e.g. cattle, buffalo, sheep and goats), either following vaccination or infection, and can be used both for sero-monitoring and sero-surveillance.
In common with a few other countries of the erstwhile rinderpest-infected zone in Asia and Africa, India is provisionally-free of rinderpest. Any eradication campaign is weighed scientifically not by means of mere absence of occurrence of the disease in an area, but by how rigorous the surveillance is within the area. Serological evidence is clearly important as a basis for claiming rinderpest-free status. The ELISA, and more particularly, c-ELISA, has already been proved to be the best method for rinderpest sero-surveillance and sero-monitoring. Several countries use such a c-ELISA kit accepted by international bodies such as the FAO or the Office International des Epizooties. Approximately three quarters of a billion domestic animals are likely to be under intensive surveillance for rinderpest, and this estimate includes only those countries which are currently experiencing outbreaks of rinderpest or have done so in the recent past. For the dream of global eradication of rinderpest to succeed, the existence of an additional source for the most crucial test for surveillance would be advantageous. The data on development of c-ELISA presented above is directed to meet such an objective. The reagents developed are expected to be used for sero-surveillance of rinderpest in India and also in neighbouring countries which are actively pursuing such a programme. These reagents, when presented in the form of a kit, would offer an inexpensive substitute for use in developing countries. 
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Creación y evaluación de un ensayo inmunoenzimático de competición con anticuerpos monoclonales para detectar anticuerpos contra el virus de la peste bovina R.P. Singh, B.P. Sreenivasa, P. Dhar, R.N. Roy & S.K. Bandyopadhyay
Resumen
Los autores describen un ensayo inmunoenzimático de competición estandarizado para la detección de anticuerpos contra el virus de la peste bovina en suero de bovinos, ovinos y caprinos. Para esta prueba se utiliza un anticuerpo monoclonal neutralizante dirigido contra una proteína (hemaglutinina) del virus de la peste bovina. Esta prueba es específica de la peste bovina, ya que no detectó anticuerpos contra el virus de la peste de pequeños rumiantes en el suero de cabras convalecientes. Para definir el carácter positivo o negativo de las muestras analizadas, se utilizó un punto final correspondiente a un 45% de inhibición de la unión del anticuerpo monoclonal con el antígeno. Tras determinarse la especificidad y sensibilidad de la prueba, así como la estabilidad de los reactivos utilizados en ella, se compararon esos parámetros con los resultados que ofrece un kit comercial, para lo cual se analizaron unas 1.200 muestras séricas de bovinos, ovinos y caprinos de la India. La prueba del estudio funcionó muy bien en comparación con el ensayo comercial, por lo que se le augura una gran utilidad para actividades de seroseguimiento y serovigilancia de la peste bovina en países donde se aplican activamente campañas de erradicación de la enfermedad.
